March 16, 2020 / 12:26 PM / 16 days ago

BRIEF-Unum Therapeutics - Co Was Notified By FDA That Partial Clinical Hold On Phase 1 Trial Of Actr707 In Combination With Rituximab Has Been Lifted

March 16 (Reuters) - Unum Therapeutics Inc:

* UNUM THERAPEUTICS - CO WAS NOTIFIED BY FDA THAT PARTIAL CLINICAL HOLD ON PHASE 1 TRIAL OF ACTR707 IN COMBINATION WITH RITUXIMAB HAS BEEN LIFTED Source text for Eikon: bit.ly/38TbgWk Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below